Edition:
United Kingdom

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

52.63USD
18 Apr 2019
Change (% chg)

$0.09 (+0.17%)
Prev Close
$52.54
Open
$52.44
Day's High
$53.16
Day's Low
$52.28
Volume
3,617,664
Avg. Vol
2,774,004
52-wk High
$82.12
52-wk Low
$51.77

Latest Key Developments (Source: Significant Developments)

CVS Health Corp Says CEO Larry Merlo's FY 2018 Total Compensation Was $21.9 Million
Friday, 5 Apr 2019 

April 5 (Reuters) - CVS Health Corp ::CVS HEALTH CORP SAYS CEO LARRY MERLO'S FY 2018 TOTAL COMPENSATION WAS $21.9 MILLION VERSUS $23.3 MILLION IN FY 2017 - SEC FILING.CVS HEALTH CORP SAYS COO JONATHAN ROBERTS' FY 2018 TOTAL COMPENSATION WAS $16.1 MILLION VERSUS $6.9 MILLION IN FY 2017.CVS HEALTH CORP SAYS RATIO OF CEO ANNUAL COMPENSATION TO MEDIAN EMPLOYEE FOR 2018 IS 618-TO-1.  Full Article

Aetna Heads A $25 Mln Investment Round Into Map Health Management
Thursday, 7 Mar 2019 

March 7 (Reuters) - CVS Health Corp ::AETNA HEADS A $25 MILLION INVESTMENT ROUND INTO MAP HEALTH MANAGEMENT.MAP HEALTH MANAGEMENT - COMPLETION OF $25 MILLION PLACEMENT OF SERIES A PREFERRED AND COMMON UNITS IN A ROUND HEADED BY AETNA, A CVS HEALTH BUSINESS.  Full Article

CVS CEO Says Sees Proposed Rebate Rule "Taking Us Backwards Not Forward"
Wednesday, 20 Feb 2019 

Feb 20 (Reuters) - CVS Health Corp ::CVS HEALTH CORP SAYS PRICES FOR NON SPECIALTY MEDICATIONS FELL 4.2 PERCENT FOR COMMERCIAL CLIENTS; PRICES FOR SPECIALTY PRODUCTS GREW 1.7 PERCENT IN 2018.CVS HEALTH CORP SAYS OPERATING INCOME FOR PBM BUSINESS WILL BE DOWN MID-SINGLE DIGITS VERSUS 2018 - CONF. CALL.CVS SAYS ANTHEM PBM CONTRACT IS A "STRONG HEADWIND" DUE TO INVESTMENT NEEDED TO ACCELERATE START DATE.CVS CEO SAYS SEES PROPOSED REBATE RULE "TAKING US BACKWARDS NOT FORWARD" - CONF. CALL.  Full Article

CVS Health Reports Q4 Adjusted Earnings Per Share Of $2.14
Wednesday, 20 Feb 2019 

Feb 20 (Reuters) - CVS Health Corp ::CVS HEALTH REPORTS FOURTH QUARTER AND FULL YEAR RESULTS AND PROVIDES 2019 FULL YEAR GUIDANCE.Q4 ADJUSTED EARNINGS PER SHARE $2.14.Q4 GAAP LOSS PER SHARE $0.37 FROM CONTINUING OPERATIONS.Q4 EARNINGS PER SHARE ESTIMATE $2.05 -- REFINITIV IBES DATA.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $6.68 TO $6.88.SEES FY 2019 GAAP EARNINGS PER SHARE $4.88 TO $5.08 FROM CONTINUING OPERATIONS.QTRLY REVENUES INCREASED 12.5% TO $54.4 BILLION.CVS HEALTH - SEES 2019 CASH FLOW FROM OPERATIONS BETWEEN $9.8 BILLION TO $10.3 BILLION.Q4 GAAP LOSS PER SHARE FROM CONTINUING OPERATIONS INCLUDED A $2.2 BILLION, OR $1.99 PER SHARE, GOODWILL IMPAIRMENT CHARGE RELATED TO LTC BUSINESS.Q4 REVENUE VIEW $54.58 BILLION -- REFINITIV IBES DATA.  Full Article

Omega Advisors Reports Share Stake Of 795,900 Shares In CVS Health As Of Dec 31 Vs 394,600 Shares As Of Sept 30
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - Omega Advisors: :OMEGA ADVISORS REPORTS SHARE STAKE OF 795,900 SHARES IN CVS HEALTH CORP AS OF DEC 31 VERSUS 394,600 SHARES AS OF QUARTER ENDED SEPT 30, 2018 - SEC FILING.OMEGA ADVISORS - CHANGE IN HOLDINGS ARE AS OF DECEMBER 31, 2018 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF SEPTEMBER 30, 2018.  Full Article

Aetna Announces Attain, Which Combines Health History With Apple Watch Information
Tuesday, 29 Jan 2019 

Jan 29 (Reuters) - CVS Health -:AETNA ANNOUNCES ATTAIN, A PERSONALIZED WELL-BEING EXPERIENCE THAT COMBINES HEALTH HISTORY WITH APPLE WATCH INFORMATION TO EMPOWER BETTER HEALTH.LAUNCH BUILDS ON 2016 COLLABORATION BETWEEN AETNA AND APPLE; ATTAIN APP IS EXPECTED TO BE AVAILABLE IN APPLE APP STORE IN SPRING 2019.  Full Article

Walmart Remains "Focused On Continuing Discussions With CVS Caremark"
Tuesday, 15 Jan 2019 

Jan 15 (Reuters) - Walmart Inc ::WALMART REMAINS "FOCUSED ON CONTINUING DISCUSSIONS WITH CVS CAREMARK AND TRYING TO FIND A SOLUTION THAT BENEFITS ALL PARTIES" - SPOKESPERSON.  Full Article

Walmart Expected To Leave CVS Caremark Pharmacy Network Amid Dispute - WSJ
Tuesday, 15 Jan 2019 

Jan 15 (Reuters) - :WALMART EXPECTED TO LEAVE CVS CAREMARK PHARMACY NETWORK AMID DISPUTE - WSJ.CVS HAS ASKED WALMART TO REMAIN IN ITS NETWORKS THROUGH APRIL 30. IF WALMART DOESN'T AGREE,SPLIT WILL TAKE EFFECT IN EARLY FEB. - WSJ CITING SOURCE.  Full Article

Aetna Inc Announces Final Regulatory Approval for CVS Health's Acquisition of Co
Monday, 26 Nov 2018 

Nov 26 (Reuters) - Aetna Inc ::AETNA INC - CLOSING OF CVS HEALTH TRANSACTION IS EXPECTED TO OCCUR ON OR ABOUT NOVEMBER 28, 2018.AETNA INC - AETNA INC - CO AND CVS HEALTH RECEIVED THE FINAL REGULATORY APPROVAL REQUIRED FOR CVS HEALTH TO COMPLETE ITS ACQUISITION OF AETNA.  Full Article

Aetna Inc - James Clark Appointed As CVS Health’S Senior Vice President
Tuesday, 20 Nov 2018 

Nov 20 (Reuters) - Aetna Inc ::AETNA INC - ON NOV 19, CVS HEALTH ANNOUNCED EVA C. BORATTO HAS BEEN APPOINTED EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER.AETNA INC - CVS HEALTH APPOINTED JAMES D. CLARK HAS BEEN APPOINTED AS CVS HEALTH’S SENIOR VICE PRESIDENT.  Full Article

Photo

Lagging U.S. healthcare stocks could see short-term boost but clouds linger

NEW YORK Second-quarter strength in U.S. healthcare stocks is almost as reliable for Americans as warming weather and the start of baseball season. This year, however, the already-lagging sector may struggle to sustain any kind of rally.